GlassScriptPhysician profile
Ali Hazama
NPI 1386080158
$83,019.44
in general payments reported to CMS, 2019-2025
23 companies · $15K in 2025
The $15K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,779 · 2021: $2,913 · 2022: $3,602 · 2023: $32K · 2024: $27K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $29K · Consulting Fee: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $5,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $28,887.31 |
| Consulting Fee | $22,742.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,500.00 |
| Food and Beverage | $5,595.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $71,285.20 | 2022-2025 | Optimesh Expandable Interbody Fusion System |
| Seaspine Orthopedics Corporation | $3,233.00 | 2020-2022 | |
| Medical Device Business Services, INC. | $2,573.26 | 2020-2021 | |
| Synergy Biomedical, LLC | $1,875.00 | 2022 | |
| Depuy Synthes Sales INC. | $1,138.13 | 2020-2025 | Teligen, Fibergraft Bg Morsels, Motoband |
| Medtronic, INC. | $613.86 | 2022-2025 | Mazor X System, Anatomic Peek Ptc Cervical Fusion System, Intellis Adaptivestim |
| Globus Medical, INC. | $498.96 | 2024-2025 | Excelsius Deformity, Creo, Excelsiusgps Robotic Navigation System |
| Intrinsic Therapeutics | $231.45 | 2023 | Barricaid Acd (Annular Closure Device) |
| Si-Bone, INC. | $203.84 | 2025 | |
| Icotec Medical INC. | $186.27 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm |
| Boston Scientific Corporation | $170.61 | 2020-2022 | |
| Kuros Biosciences USA, INC | $149.15 | 2023 | |
| Alphatec Spine, INC | $145.76 | 2024 | Other - Miscellaneous |
| Lifenet Health | $104.50 | 2025 | Optium (Tgel & Tput) |
| Lenoss Medical INC | $101.13 | 2024 | Access & Cavity Creation Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $93.11 | 2025 | Prodisc C Vivo |
| Medtronic USA, INC. | $91.88 | 2020 | |
| Spinal Simplicity, LLC | $90.25 | 2024 | Ha Minuteman G3-R |
| Baxter Healthcare | $78.13 | 2024 | Tisseel |
| Acelrx Pharmaceuticals, INC. | $74.21 | 2021 | |
| Integra Lifesciences Corporation | $48.15 | 2023 | Codman Hakim, Cusa Clarity, Codman Certas |
| Atlas Spine, INC. | $17.01 | 2021 | |
| Carbofix Spine INC | $16.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Hazama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.